A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Inovytec Named Smart 50 Awards Recipient for Development of Smart Critical Aid Solution, SALI

Inovytec, a developer of medical devices that address emergency and routine respiratory and cardiac care, announced today that it has been recognized by the 2021 Smart 50 Awards for the implementation of SALI, a clinically proven, smart critical aid system that enables bystanders to provide treatment to people experiencing a medical emergency.

The Smart 50 Awards, in partnership with Smart Cities Connect, Smart Cities Connect Foundation, and US Ignite, annually recognize the most innovative and influential global smart city projects.

SALI, housed in a small case, is placed in public areas around a city. When someone experiences a cardiac or medical emergency, a bystander can easily deploy the SALI and place the patient on a headrest inside. The device is equipped with tools for non-invasive airway management, automated oxygen therapy, vital monitoring, and defibrillation. A video screen inside guides the bystander through providing basic first aid and attaching the monitoring tools. SALI also automatically connects to an emergency dispatch center, enabling interactive instruction from a medical professional and real-time transmission of vital signs for improved treatment and outcomes.

A study of the SALI’s implementation in Marburg, Germany found that the SALI reduced the time to first medical treatment by six minutes and 12 seconds. This time is critical for improving patient outcomes and reducing neurological damage. SALI was also chosen to be part of a national project in Romania, led by the Deputy Minister responsible for Emergency Healthcare and Services. Initial deployment is 240 devices in supermarkets and 140 in the municipal areas of Bucharest.

“The smart city revolution centers on utilizing new technology for the betterment of millions of people,” said Inovytec CEO Udi Kantor. “SALI helps cities create connected safe zones within which people are significantly more protected in emergency situations. It empowers community members to be responsible for one another and take action before the arrival of the emergency response team. We are honored to win this award and I’m proud of our team for helping to push patient safety forward.”

SourceInovytec
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy